Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02968225
Other study ID # R61MH110624
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date August 2016
Est. completion date October 2018

Study information

Verified date March 2021
Source Penn State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators hypothesize that this serious game (designed to provide a learning environment that maximizes opportunities for adolescents with autism to discover the functional utility of eye gaze) will improve sensitivity to eye gaze cues, specifically to identify gazed-at objects, and will also lead to increased social attention to faces in adolescents with autism. The investigators will test this hypothesis in a small-scale exploratory randomized control trial that will include both behavioral and eye tracking outcome measures.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date October 2018
Est. primary completion date October 2018
Accepts healthy volunteers No
Gender All
Age group 10 Years to 18 Years
Eligibility Inclusion criteria: 1. parent/caregiver of an adolescent with a diagnosis of ASD, 2. parent/caregiver and adolescent with ASD both native English speakers, 3. adolescent with ASD aged between 10-18 years at enrollment, 4. adolescent has normal vision and hearing with correction as indicated by parent report, 5. adolescent is able to use a computer for the purposes of game play, 6. adolescent scores > 80% correct (i.e., 0.5 SD less than M of TD adolescents) on online eye gaze screening task, 7. ASD diagnosis of adolescent confirmed in lab via the Autism Diagnostic Observation Schedule, 8. Full Scale IQ of adolescent determined to be between 70-130 on the Kaufman Brief Intelligence Test, 9. reading ability of adolescent determined to be at least a second grade level as assessed by the Oral and Written Language Scales, 10. adolescent is capable of cooperating with testing, 11. parent/caregiver and adolescent both consent/assent to participate in the research. Exclusion Criteria 1. adolescent has had seizures within the previous two years, 2. family lacks stable home internet, 3. parent or adolescent refuses to consent/assent to take part in the research, 4. adolescent is 18 and has a legal guardian, prohibiting him/her from legally consenting, or 5. adolescent is 18 and cannot understand the consent (i.e., fails consent quiz).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Computer Game
The game involves viewing subtle nonverbal behaviors of game characters for the purpose of executing their own goal-directed behavior in the game related to solving various crimes. The learning involves interpreting nonverbal cues on the animated characters, such as pointing, head turns, eye gaze cues.

Locations

Country Name City State
United States Pennsylvania State University University Park Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Penn State University National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Static Eye Gaze Following Task Eye tracking and accuracy 2 months
Primary Dynamic Eye Gaze Following Task Eye tracking and accuracy 2 Months
Primary Social/Visual Attention Task Eye tracking 2 Months
Secondary Social Responsiveness Scale Parents completing measure of autism-like behavior in adolescents 2 months
Secondary Social Skills Inventory System - Child version Adolescents completing measure of social skills and problem behaviors in themselves 2 months
Secondary Social Skills Inventory System - Adult version Parents completing measure of social skills and problem behaviors in adolescents 2 months
Secondary Treatment as Usual Parents reporting on social and behavioral treatments adolescents receiving in and out of school 2 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05302167 - Molehill Mountain Feasibility Study. N/A
Completed NCT04167839 - Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement N/A
Terminated NCT04049981 - Investigation of Mechanisms of Action in Superpower Glass Phase 1/Phase 2
Active, not recruiting NCT06080087 - Implementation Toolkit to Enhance EBP Among Marginalized Families N/A
Recruiting NCT04107064 - Achieving Steady Work Among Adults With Autism Through Specialized Employment Program N/A
Completed NCT03206996 - Exposure Therapy for Auditory Sensitivity in Autism N/A
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Completed NCT05588570 - Coaching Children With Anxiety and Autism Through Telehealth N/A
Enrolling by invitation NCT06058104 - Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism N/A
Completed NCT02847182 - Cord Blood Infusion for Children With Autism Spectrum Disorder Phase 2
Withdrawn NCT02414451 - Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response N/A
Completed NCT03002363 - The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance Phase 1
Completed NCT02911194 - a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT02508922 - Trial of Vitamin D3 Supplementation in Paediatric Autism N/A
Completed NCT02536365 - Sensory Integration Therapy in Autism: Mechanisms and Effectiveness N/A
Completed NCT02708290 - Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
Completed NCT02720900 - Prebiotic Intervention for Autism Spectrum Disorders N/A
Recruiting NCT02255565 - Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study Phase 4
Recruiting NCT01836562 - A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism Phase 1/Phase 2
Completed NCT02154828 - Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)